Lymphocyte senescence in COPD is associated with loss of glucocorticoid receptor expression by pro-inflammatory/cytotoxic lymphocytes
Open Access
- 9 January 2015
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 16 (1) , 2
Abstract
Glucocorticoid (GC) resistance is a major barrier in COPD treatment. We have shown increased expression of the drug efflux pump, Pgp1 in cytotoxic/pro-inflammatory lymphocytes in COPD. Loss of lymphocyte co-stimulatory molecule CD28 (lymphocyte senescence) was associated with a further increase in their pro-inflammatory/cytotoxic potential and resistance to GC. We hypothesized that lymphocyte senescence and increased Pgp1 are also associated with down-regulation of the GC receptor (GCR). Blood was collected from 10 COPD and 10 healthy aged-matched controls. Flow cytometry was applied to assess intracellular pro-inflammatory cytokines, CD28, Pgp1, GCR, steroid binding and relative cytoplasm/nuclear GCR by CD28+ and CD28null T, NKT-like cells. GCR localization was confirmed by fluorescent microscopy. COPD was associated with increased numbers of CD28nullCD8+ T and NKT-like cells. Loss of CD28 was associated with an increased percentage of T and NKT-like cells producing IFNγ or TNFα and associated with a loss of GCR and Dex-Fluor staining but unchanged Pgp1. There was a significant loss of GCR in CD8 + CD28null compared with CD8 + CD28+ T and NKT-like cells from both COPD and controls (eg, mean ± SEM 8 ± 3% GCR + CD8 + CD28null T-cells vs 49 ± 5% GCR + CD8 + CD28+ T-cells in COPD). There was a significant negative correlation between GCR expression and IFNγ and TNFα production by T and NKT-like cells(eg, COPD: T-cell IFNγ R = −.615; ) and with FEV1 in COPD (R = −.777). COPD is associated with loss of GCR in senescent CD28null and NKT-like cells suggesting alternative treatment options to GC are required to inhibit these pro-inflammatory/cytotoxic cells.Keywords
This publication has 29 references indexed in Scilit:
- The drug efflux pump Pgp1 in pro-inflammatory lymphocytes is a target for novel treatment strategies in COPDRespiratory Research, 2013
- Role of histone deacetylase 2 in epigenetics and cellular senescence: implications in lung inflammaging and COPDAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2012
- Selective Glucocorticoid Receptor Agonists for the Treatment of Inflammatory Bowel Disease: Studies in Mice with Acute Trinitrobenzene Sulfonic Acid ColitisThe Journal of Pharmacology and Experimental Therapeutics, 2012
- T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary diseaseRespiratory Research, 2012
- Role of increased CD8/CD28null T cells and alternative co-stimulatory molecules in chronic obstructive pulmonary diseaseClinical and Experimental Immunology, 2011
- Successful Treatment of Acute Lung Injury with Pitavastatin in Septic Mice: Potential Role of Glucocorticoid Receptor Expression in Alveolar MacrophagesThe Journal of Pharmacology and Experimental Therapeutics, 2011
- T cell activation profiles in different granulomatous interstitial lung diseases – a role for CD8+CD28null cells?Clinical and Experimental Immunology, 2009
- Skewed distribution of proinflammatory CD4+CD28nullT cells in rheumatoid arthritisArthritis Research & Therapy, 2007
- Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjectsClinical and Experimental Immunology, 2007
- CD28 extinction in human T cells: altered functions and the program of T‐cell senescenceImmunological Reviews, 2005